Capital Market Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Capital Market Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$416K	Hold	1,027	–	–	0.29%	66
2025 Q1	$511K	Sell	1,027 -163	-14%	-$88.3K	0.34%	56
2024 Q4	$619K	Sell	1,190 -8	-0.7%	-$4.4K	0.36%	56
2024 Q3	$741K	Hold	1,198	–	–	0.45%	44
2024 Q2	$662K	Sell	1,198 -52	-4%	-$29.8K	0.42%	46
2024 Q1	$727K	Hold	1,250	–	–	0.55%	44
2023 Q4	$663K	Buy	1,250 +1	+0.1%	+$484	0.58%	43
2023 Q3	$624K	Sell	1,249 -103	-8%	-$54.9K	0.62%	37
2023 Q2	$705K	Buy	+1,352	New	+$730K	0.65%	36
2023 Q1	–	Sell	-1,338	Closed	-$737K	–	122
2022 Q4	$737K	Hold	1,338	–	–	0.79%	32
2022 Q3	$679K	Buy	1,338 +34	+3%	+$19K	0.76%	33
2022 Q2	$708K	Hold	1,304	–	–	0.74%	34
2022 Q1	$770K	Buy	1,304 +2	+0.2%	+$1.15K	0.67%	36
2021 Q4	$869K	Buy	+1,302	New	+$813K	0.72%	34

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital Market Strategies's TMO Position: Q2 2025 in Review

Capital Market Strategies held its Thermo Fisher Scientific (TMO) position steady in Q2 2025 at 1,027 shares worth $416K. The position accounts for 0.29% of the portfolio, ranked #66.

Capital Market Strategies first reported a position in TMO in Q4 2021 and has held it in 14 quarters since. The position peaked at $869K in Q4 2021. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Capital Market Strategies held 1,027 shares of Thermo Fisher Scientific worth $416K as of Q2 2025.
Capital Market Strategies left its Thermo Fisher Scientific share count unchanged in Q2 2025.
Thermo Fisher Scientific made up 0.29% of Capital Market Strategies's portfolio in Q2 2025, its #66 holding.
Capital Market Strategies first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 14 quarters since.
Capital Market Strategies's Thermo Fisher Scientific position peaked at $869K in Q4 2021.
2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.